Drug discovery has long been one of the slowest and most expensive parts of modern medicine. Isomorphic Labs, a drug discovery startup spun out of Google DeepMind, wants artificial intelligence to change that, and investors are betting billions that it can. […]

The post Alphabet-backed Isomorphic Labs raises $2.1B to accelerate AI-designed drug discovery as clinical trials near first appeared on Tech Startups.